BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10830282)

  • 1. Hexosamines stimulate leptin production in transgenic mice.
    McClain DA; Alexander T; Cooksey RC; Considine RV
    Endocrinology; 2000 Jun; 141(6):1999-2002. PubMed ID: 10830282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.
    Hazel M; Cooksey RC; Jones D; Parker G; Neidigh JL; Witherbee B; Gulve EA; McClain DA
    Endocrinology; 2004 May; 145(5):2118-28. PubMed ID: 14684615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid.
    McClain DA; Hazel M; Parker G; Cooksey RC
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E973-9. PubMed ID: 15613679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance.
    Tang J; Neidigh JL; Cooksey RC; McClain DA
    Diabetes; 2000 Sep; 49(9):1492-9. PubMed ID: 10969833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione.
    Cooksey RC; Hebert LF; Zhu JH; Wofford P; Garvey WT; McClain DA
    Endocrinology; 1999 Mar; 140(3):1151-7. PubMed ID: 10067838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hexosamines in insulin resistance and nutrient sensing in human adipose and muscle tissue.
    Pouwels MJ; Tack CJ; Span PN; Olthaar AJ; Sweep CG; Huvers FC; Lutterman JA; Hermus AR
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5132-7. PubMed ID: 15472217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance.
    Veerababu G; Tang J; Hoffman RT; Daniels MC; Hebert LF; Crook ED; Cooksey RC; McClain DA
    Diabetes; 2000 Dec; 49(12):2070-8. PubMed ID: 11118009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexosamines as mediators of nutrient sensing and regulation in diabetes.
    McClain DA
    J Diabetes Complications; 2002; 16(1):72-80. PubMed ID: 11872372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased hexosamine pathway flux and high fat feeding are not additive in inducing insulin resistance: evidence for a shared pathway.
    Cooksey RC; McClain DA
    Amino Acids; 2011 Mar; 40(3):841-6. PubMed ID: 20658157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat.
    Wang J; Liu R; Hawkins M; Barzilai N; Rossetti L
    Nature; 1998 Jun; 393(6686):684-8. PubMed ID: 9641678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice overexpressing the rate-limiting enzyme for hexosamine synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance.
    Cooksey RC; McClain DA
    Ann N Y Acad Sci; 2002 Jun; 967():102-11. PubMed ID: 12079840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexosamines, insulin resistance, and the complications of diabetes: current status.
    Buse MG
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of glutamine:fructose-6-phosphate amidotransferase in rat-1 fibroblasts enhances glucose-mediated glycogen accumulation via suppression of glycogen phosphorylase activity.
    Crook ED; Crenshaw G; Veerababu G; Singh LP
    Endocrinology; 2000 Jun; 141(6):1962-70. PubMed ID: 10830278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexosamines regulate leptin production in human subcutaneous adipocytes.
    Considine RV; Cooksey RC; Williams LB; Fawcett RL; Zhang P; Ambrosius WT; Whitfield RM; Jones R; Inman M; Huse J; McClain DA
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3551-6. PubMed ID: 11061500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine: fructose-6-phosphate amidotransferase activity and gene expression are regulated in a tissue-specific fashion in pregnant rats.
    Yki-Järvinen H; Nyman T; Rissanen E; Leino M; Hämäläinen S; Virkamäki A; Hauguel-de Mouzon S
    Life Sci; 1999; 65(2):215-23. PubMed ID: 10416827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues.
    Virkamäki A; Daniels MC; Hämäläinen S; Utriainen T; McClain D; Yki-Järvinen H
    Endocrinology; 1997 Jun; 138(6):2501-7. PubMed ID: 9165041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance.
    Hebert LF; Daniels MC; Zhou J; Crook ED; Turner RL; Simmons ST; Neidigh JL; Zhu JS; Baron AD; McClain DA
    J Clin Invest; 1996 Aug; 98(4):930-6. PubMed ID: 8770864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of glycogen synthase and protein phosphatase-1 by hexosamines.
    Crook ED; McClain DA
    Diabetes; 1996 Mar; 45(3):322-7. PubMed ID: 8593937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose regulation of transforming growth factor-alpha expression is mediated by products of the hexosamine biosynthesis pathway.
    Daniels MC; Kansal P; Smith TM; Paterson AJ; Kudlow JE; McClain DA
    Mol Endocrinol; 1993 Aug; 7(8):1041-8. PubMed ID: 8232303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased body fat mass and suppression of circulating leptin levels in response to hypersecretion of epinephrine in phenylethanolamine-N-methyltransferase (PNMT)-overexpressing mice.
    Böttner A; Haidan A; Eisenhofer G; Kristensen K; Castle AL; Scherbaum WA; Schneider H; Chrousos GP; Bornstein SR
    Endocrinology; 2000 Nov; 141(11):4239-46. PubMed ID: 11089558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.